Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $75.62 ($1.9M) on 2019-02-28, disclosed to the SEC on 2019-03-01.
Open-market sale of $1.9M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.62 | 5,302 | $401K | 21.0% |
| 2 | $76.41 | 14,900 | $1.1M | 59.6% |
| 3 | $77.22 | 4,798 | $371K | 19.4% |
| Total | $76.40 avg | 25,000 | $1.9M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $1.3M | — | Filing → |